Invex Therapeutics’ new partnership de-risks Presendin development

(25:37)

ASX Small \u0026 Mid Cap Conference: Invex Therapeutics

(23:47)

Invex Therapeutics Presentation - 2021 NWR Virtual Investor Conference

(29:9)

Invex Therapeutics rolls-out Evolve phase III trial for drug Presendin in IIH patients

(23:29)

Invex Therapeutics (ASX:IXC) - Broker Briefing Tech \u0026 Biotech Investor Webinar - March 2022

(21:12)

Invex Therapeutics (ASX:IXC) - Presentation to Broker Briefing 24th March 2022

(21:12)

Invex Therapeutics 2021 Annual General Meeting of Shareholders

(26:17)

Invex Therapeutics (ASX:IXC) Approval to commence clinical trial

(21)

Invex Therapeutics IIH EVOLVE Closure

(29:17)

Invex Therapeutics (ASX:IXC): TSN - The Stock Network presentation

(7:26)

Invex Therapeutics Quarterly Investor Call

(12:26)

Invex Therapeutics Collaboration \u0026 Manufacturing Agreement with Peptron - Investor Presentation

(19:38)

Invex Therapeutics Q3 FY22 Investor Presentation

(14:46)

Invex Therapeutics (ASX:IXC) Fourth Quarter FY22 Investor Call

(14:45)

Invex Therapeutics (ASX:IXC) Clinical and Regulatory Strategy - Investor Webinar

(42:2)

Invex Therapeutics (ASX:IXC): Emerging ASX Gems presentation

(7:26)

Invex Therapeutics Q2 FY23 Conference Call

(15:49)

Invex Therapeutics (ASX:IXC) - Third Quarter FY22 Investor Call

(13:12)

Invex 2020 AGM Webcast

(27:10)